Literature DB >> 22733223

Renal complications following lung and heart-lung transplantation.

Paul D Robinson1, Rukshana C Shroff, Helen Spencer.   

Abstract

As survival improves after lung and heart-lung transplants, the long term detrimental impact of current management on renal function becomes more apparent as the number of non-renal solid organ transplant recipients on renal transplant waiting lists increases. Progressive chronic kidney disease (CKD) is a significant cause of morbidity and mortality in the transplant population. In this review we discuss the specific problems prior to lung or heart-lung transplant that predispose to CKD, as well as potential renal complications encountered during the peri- and post-transplant period. Significant acute and chronic nephrotoxicity is caused by calcineurin inhibitors (CNI). Mechanisms to decrease CNI exposure exist but have yet to be adopted in routine clinical care. Modifiable risk factors and the current screening and management approach taken at our institution are described. Pediatric nephrologists should be involved from an early stage. Future work will need to focus on identifying more accurate measures of renal function, given the limitations of current glomerular filtration rate estimation equations in a population where nutritional status may rapidly change post transplant. Multicentre studies of CNI minimisation strategies are required to guide future therapy that aims to minimise CKD development and progression in this vulnerable population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733223     DOI: 10.1007/s00467-012-2200-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  74 in total

1.  The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Heart Transplantation Report--2011.

Authors:  Richard Kirk; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Fabienne Dobbels; Axel O Rahmel; Josef Stehlik; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2011-10       Impact factor: 10.247

2.  The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Lung and Heart-Lung Transplantation Report--2011.

Authors:  Christian Benden; Paul Aurora; Leah B Edwards; Anna Y Kucheryavaya; Jason D Christie; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2011-10       Impact factor: 10.247

Review 3.  The place of sirolimus in kidney transplantation: can we reduce calcineurin inhibitor renal toxicity?

Authors:  R J Knight; B D Kahan
Journal:  Kidney Int       Date:  2006-07-26       Impact factor: 10.612

4.  Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors.

Authors:  K C Mange; M M Joffe; H I Feldman
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation.

Authors:  M Canales; P Youssef; R Spong; A Ishani; K Savik; M Hertz; H N Ibrahim
Journal:  Am J Transplant       Date:  2006-07-06       Impact factor: 8.086

6.  Treatment of end-stage renal failure after heart transplantation.

Authors:  L Frimat; J P Villemot; L Cormier; T Cao-Huu; E Renoult; D Hestin; C Dopff; S Mattéi; J Hubert; M Kessler
Journal:  Nephrol Dial Transplant       Date:  1998-11       Impact factor: 5.992

7.  The profile of renal function over time in a cohort of pediatric heart transplant recipients.

Authors:  Winston Bharat; Cedric Manlhiot; Brian W McCrindle; Stacey Pollock-BarZiv; Anne I Dipchand
Journal:  Pediatr Transplant       Date:  2007-12-18

8.  Standard dosing of tacrolimus leads to overexposure in pediatric renal transplantation recipients.

Authors:  Joshua Y Kausman; Bhumik Patel; Stephen D Marks
Journal:  Pediatr Transplant       Date:  2008-05

9.  Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.

Authors:  B Kasiske; F G Cosio; J Beto; K Bolton; B M Chavers; R Grimm; A Levin; B Masri; R Parekh; C Wanner; D C Wheeler; P W F Wilson
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

10.  Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.

Authors:  Y Fan; Y-B Xiao; Y-G Weng
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

View more
  7 in total

Review 1.  The Evolution of Lung Transplant Immunosuppression.

Authors:  Steven Ivulich; Glen Westall; Michael Dooley; Gregory Snell
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

2.  Targeted Training for Subspecialist Care in Children With Medical Complexity.

Authors:  Fabian Eibensteiner; Valentin Ritschl; Isabella Valent; Rebecca Michaela Schaup; Axana Hellmann; Lukas Kaltenegger; Lisa Daniel-Fischer; Krystell Oviedo Flores; Stefan Brandstaetter; Tanja Stamm; Eva Schaden; Christoph Aufricht; Michael Boehm
Journal:  Front Pediatr       Date:  2022-05-16       Impact factor: 3.569

3.  Acute kidney injury after heart transplant in young children: risk factors and outcomes.

Authors:  Christine MacDonald; Colleen Norris; Gwen Y Alton; Simon Urschel; Ari R Joffe; Catherine J Morgan
Journal:  Pediatr Nephrol       Date:  2015-11-11       Impact factor: 3.714

Review 4.  Acute kidney injury after lung transplantation: a narrative review.

Authors:  Lei Jing; Wenhui Chen; Lijuan Guo; Li Zhao; Chaoyang Liang; Jingyu Chen; Chen Wang
Journal:  Ann Transl Med       Date:  2021-04

Review 5.  Peri-operative kidney injury and long-term chronic kidney disease following orthotopic heart transplantation in children.

Authors:  Aparna Hoskote; Michael Burch
Journal:  Pediatr Nephrol       Date:  2014-08-14       Impact factor: 3.714

Review 6.  HLA sensitisation: can it be prevented?

Authors:  Lesley Rees; Jon Jin Kim
Journal:  Pediatr Nephrol       Date:  2014-07-26       Impact factor: 3.714

Review 7.  Review: immunosuppression for the lung transplant patient.

Authors:  Sakhee Kotecha; Steven Ivulich; Gregory Snell
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.